Since highly pathogenic avian influenza virus (HPAIV) spread to the island of South Georgia in the sub-Antarctic in 2023, its ...

A previously healthy New Jersey man has been identified by an allergist at the University of Virginia (UVA) and his coauthors ...

Hundreds of malaria patients enrolled in a phase 3 clinical trial in Gabon, West Africa, were successfully treated with a one ...

Earlier this month, a group of Canadian researchers published early influenza data for the 2025-26 season, issuing a warning: ...

Developed by British drugmaker GSK, RTS,S/AS01E in 2021 became the first malaria vaccine to be recommended by the World ...

The adjusted incident rate ratio (IRR) for GBS post-RSV disease was 2.11, reflecting a slightly more than double risk. The ...

Infection with the mpox virus (MPXV) confers strong immunity against future infection for up to two years, compared with ...

At three months, relative to controls, greater improvements in intervention recipients were also seen for depression and ...

A large study of US adults 65 and older enrolled in Medicare finds that the risk of Guillain-Barre syndrome (GBS)—a rare ...

Over the weekend Utah and South Carolina, the current hot spots of measles activity in the United States, saw case counts ...

The researchers found that RSV vaccination was 82.3% effective in protecting against hospital admission for participants with ...

A phase 1 randomized controlled trial of an experimental intranasal vaccine against multiple H5N1 avian flu strains generated ...